Hui Tian, Ph.D., MSHM

Dr. Hui Tian joined Arog Pharmaceuticals in January 2018 and has been leading Arog’s China projects since May 2018. Dr. Tian brings over ten years of experience in biomedical and preclinical research, project management and protocol development. Prior to joining Arog, Dr. Tian worked at UT Southwestern Medical Center at Dallas as a Research Scientist studying non-small cell lung cancers and signaling proteins, where she published her research in multiple peer-reviewed medical journals, including Cancer Research, Molecular Cancer Research, and Molecular Cell. Dr. Tian completed her Ph.D. training in Biochemistry at Florida International University in 2010 and finished her Postdoctoral Research Fellowship at UT Southwestern Medical Center in 2015 and received the Scholar-in-Training scholarship. She also received her M.S. in Healthcare Management from the University of Texas at Dallas with the recognition of Scholar with Distinction in 2016, and holds an ASQ certified Six Sigma Green Belt.